Article Versions Notes

Torres-Ruiz S, Tormo E, Garrido-Cano I, Lameirinhas A, Rojo F, Madoz-Gúrpide J, Burgués O, Hernando C, Bermejo B, Martínez MT, et al. High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2023; 24(4):3601. https://doi.org/10.3390/ijms24043601

Torres-Ruiz, Sandra, Eduardo Tormo, Iris Garrido-Cano, Ana Lameirinhas, Federico Rojo, Juan Madoz-Gúrpide, Octavio Burgués, Cristina Hernando, Begoña Bermejo, María Teresa Martínez, and et al. 2023. "High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer" International Journal of Molecular Sciences 24, no. 4: 3601. https://doi.org/10.3390/ijms24043601

Torres-Ruiz, S., Tormo, E., Garrido-Cano, I., Lameirinhas, A., Rojo, F., Madoz-Gúrpide, J., Burgués, O., Hernando, C., Bermejo, B., Martínez, M. T., Lluch, A., Cejalvo, J. M., & Eroles, P. (2023). High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 24(4), 3601. https://doi.org/10.3390/ijms24043601